HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The demonstration of human papillomavirus 16 genomes in the nuclei of genital cancers using two different methods of in situ hybridization.

Abstract
Biopsy specimens of 16 invasive genital cancers (two vulval carcinomas, two carcinomas of the vagina, and 12 cervix carcinomas) were examined for the presence and distribution of human papillomavirus (HPV) DNA by in situ hybridization with 3H-labeled and biotinylated DNA probes of HPV 6, HPV 11, and HPV 16. None of the tumors reacted with HPV 6 or HPV 11. Using in situ hybridization with 3H-labeled DNA probes nine of the 16 cancers gave positive results with HPV 16. Only three of the nine were positive for HPV 16 by in situ hybridization with biotinylated probes. Currently, the method of in situ hybridization with commercial biotinylated probes is less sensitive than in situ hybridization with 3H-labeled HPV DNA.
AuthorsE I Grussendorf-Conen, S Cremer
JournalCancer (Cancer) Vol. 65 Issue 2 Pg. 238-41 (Jan 15 1990) ISSN: 0008-543X [Print] United States
PMID2153043 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Probes, HPV
  • DNA, Viral
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell (microbiology)
  • DNA Probes, HPV
  • DNA, Viral (analysis)
  • Female
  • Genital Neoplasms, Female (microbiology)
  • Humans
  • Methods
  • Middle Aged
  • Nucleic Acid Hybridization
  • Papillomaviridae (genetics)
  • Tumor Virus Infections (microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: